Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Return on Invested Capital (2019 - 2020)

Moleculin Biotech (MBRX) has 1 years of Return on Invested Capital data on record, last reported at 0.05% in Q3 2020.

  • For Q3 2020, Return on Invested Capital changed N/A year-over-year to 0.05%; the TTM value through Sep 2020 reached 0.05%, changed N/A, while the annual FY2019 figure was 0.18%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.05% in Q3 2020 per MBRX's latest filing.
  • Across five years, Return on Invested Capital topped out at 0.05% in Q3 2020 and bottomed at 0.05% in Q3 2020.